Masimo Return on Tangible Equity 2010-2024 | MASI
Current and historical return on tangible equity values for Masimo (MASI) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Masimo Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-09-30 | $0.08B | $0.69B | 12.27% |
| 2024-06-30 | $0.08B | $0.65B | 13.16% |
| 2024-03-31 | $0.08B | $0.62B | 13.66% |
| 2023-12-31 | $0.08B | $0.61B | 14.41% |
| 2023-09-30 | $0.09B | $0.55B | 16.20% |
| 2023-06-30 | $0.12B | $0.56B | 21.96% |
| 2023-03-31 | $0.12B | $0.56B | 23.80% |
| 2022-12-31 | $0.14B | $0.53B | 20.30% |
| 2022-09-30 | $0.17B | $0.47B | 18.40% |
| 2022-06-30 | $0.19B | $0.43B | 16.81% |
| 2022-03-31 | $0.22B | $1.41B | 16.74% |
| 2021-12-31 | $0.23B | $1.41B | 18.06% |
| 2021-09-30 | $0.23B | $1.29B | 18.97% |
| 2021-06-30 | $0.22B | $1.21B | 18.30% |
| 2021-03-31 | $0.23B | $1.15B | 18.81% |
| 2020-12-31 | $0.24B | $1.23B | 19.72% |
| 2020-09-30 | $0.22B | $1.28B | 18.68% |
| 2020-06-30 | $0.22B | $1.21B | 19.57% |
| 2020-03-31 | $0.21B | $1.15B | 19.54% |
| 2019-12-31 | $0.20B | $1.12B | 19.02% |
| 2019-09-30 | $0.19B | $1.06B | 19.38% |
| 2019-06-30 | $0.20B | $0.99B | 21.27% |
| 2019-03-31 | $0.20B | $0.96B | 22.45% |
| 2018-12-31 | $0.19B | $0.92B | 23.72% |
| 2018-09-30 | $0.14B | $0.86B | 18.35% |
| 2018-06-30 | $0.12B | $0.78B | 16.63% |
| 2018-03-31 | $0.12B | $0.72B | 17.48% |
| 2017-12-31 | $0.13B | $0.68B | 19.30% |
| 2017-09-30 | $0.36B | $0.67B | 59.19% |
| 2017-06-30 | $0.35B | $0.66B | 68.82% |
| 2017-03-31 | $0.34B | $0.59B | 82.66% |
| 2016-12-31 | $0.31B | $0.51B | 99.13% |
| 2016-09-30 | $0.11B | $0.28B | 45.08% |
| 2016-06-30 | $0.10B | $0.25B | 44.25% |
| 2016-03-31 | $0.09B | $0.22B | 39.91% |
| 2015-12-31 | $0.08B | $0.23B | 34.55% |
| 2015-09-30 | $0.08B | $0.22B | 32.26% |
| 2015-06-30 | $0.08B | $0.24B | 30.22% |
| 2015-03-31 | $0.07B | $0.28B | 27.33% |
| 2014-12-31 | $0.07B | $0.26B | 27.44% |
| 2014-09-30 | $0.06B | $0.23B | 22.57% |
| 2014-06-30 | $0.06B | $0.27B | 22.34% |
| 2014-03-31 | $0.07B | $0.30B | 23.99% |
| 2013-12-31 | $0.06B | $0.28B | 22.92% |
| 2013-09-30 | $0.06B | $0.26B | 26.64% |
| 2013-06-30 | $0.06B | $0.24B | 25.78% |
| 2013-03-31 | $0.06B | $0.23B | 25.30% |
| 2012-12-31 | $0.06B | $0.23B | 24.56% |
| 2012-09-30 | $0.06B | $0.26B | 23.20% |
| 2012-06-30 | $0.06B | $0.28B | 23.10% |
| 2012-03-31 | $0.06B | $0.26B | 22.90% |
| 2011-12-31 | $0.06B | $0.27B | 23.99% |
| 2011-09-30 | $0.07B | $0.29B | 25.93% |
| 2011-06-30 | $0.07B | $0.27B | 27.66% |
| 2011-03-31 | $0.06B | $0.24B | 27.92% |
| 2010-12-31 | $0.07B | $0.22B | 33.49% |
| 2010-09-30 | $0.07B | $0.24B | 30.47% |
| 2010-06-30 | $0.07B | $0.22B | 28.39% |
| 2010-03-31 | $0.07B | $0.20B | 27.15% |
| 2009-12-31 | $0.05B | $0.28B | 20.85% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.238B | $2.048B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $202.584B | 24.71 |
| Intuitive Surgical (ISRG) | United States | $193.049B | 100.93 |
| Alcon (ALC) | Switzerland | $43.825B | 29.32 |
| Edwards Lifesciences (EW) | United States | $42.082B | 26.72 |
| IQVIA Holdings (IQV) | United States | $36.452B | 20.08 |
| IDEXX Laboratories (IDXX) | United States | $34.535B | 40.67 |
| DexCom (DXCM) | United States | $30.463B | 45.88 |
| Waters (WAT) | United States | $22.843B | 33.78 |
| STERIS (STE) | Ireland | $21.623B | 24.89 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.352B | 0.00 |
| Hologic (HOLX) | United States | $18.042B | 19.49 |
| Sysmex ADR (SSMXY) | Japan | $13.304B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.922B | 13.27 |
| Globus Medical (GMED) | United States | $11.657B | 29.52 |
| Penumbra (PEN) | United States | $9.369B | 91.77 |
| Teleflex (TFX) | United States | $8.957B | 14.28 |
| Glaukos (GKOS) | United States | $7.920B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.988B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.713B | 26.71 |
| Veracyte (VCYT) | United States | $3.329B | 99.88 |
| Inari Medical (NARI) | United States | $3.040B | 0.00 |
| TransMedics (TMDX) | United States | $2.910B | 92.25 |
| LivaNova (LIVN) | United Kingdom | $2.851B | 16.46 |
| Nihon Kohden (NHNKY) | Japan | $2.276B | 17.29 |
| Elekta AB (EKTAY) | Sweden | $2.261B | 20.33 |
| Tandem Diabetes Care (TNDM) | United States | $2.012B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.897B | 9.91 |
| RxSight (RXST) | United States | $1.889B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.486B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.316B | 0.00 |
| Artivion (AORT) | United States | $1.237B | 82.00 |
| OPKO Health (OPK) | United States | $1.051B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.881B | 14.97 |
| Paragon 28 (FNA) | United States | $0.863B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.746B | 0.00 |
| IRadimed (IRMD) | United States | $0.683B | 36.94 |
| Mesa Laboratories (MLAB) | United States | $0.636B | 15.00 |
| OrthoPediatrics (KIDS) | United States | $0.629B | 0.00 |
| AxoGen (AXGN) | United States | $0.612B | 0.00 |
| SiBone (SIBN) | United States | $0.569B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.531B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.523B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.473B | 27.82 |
| Tactile Systems Technology (TCMD) | United States | $0.469B | 25.38 |
| Delcath Systems (DCTH) | United States | $0.380B | 0.00 |
| CVRx (CVRX) | United States | $0.372B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.341B | 0.00 |
| NeuroPace (NPCE) | United States | $0.316B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.282B | 0.00 |
| Inogen (INGN) | United States | $0.231B | 0.00 |
| Accuray (ARAY) | United States | $0.224B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.203B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.196B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Nevro (NVRO) | United States | $0.172B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.164B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.139B | 14.93 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| 908 Devices (MASS) | United States | $0.095B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.087B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.083B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.079B | 0.00 |
| InspireMD (NSPR) | Israel | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.074B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.072B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.069B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.059B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.055B | 0.00 |
| Envoy Medical (COCH) | United States | $0.046B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.045B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.042B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.039B | 0.00 |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| Neuronetics (STIM) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.022B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.016B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.015B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |